Development of a Biomarker to Predict the Efficacy of Anti-angiogenic Therapy in Ovarian Cancer
NCT05874115
·
clinicaltrials.gov ↗
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Epithelial Ovarian Cancer
Interventions
OTHER:
liquid biopsy
Sponsor
Centro di Riferimento Oncologico - Aviano